139 related articles for article (PubMed ID: 12543220)
21. Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model.
Wu T; Ido K; Ohgoh M; Hanada T
Epilepsy Res; 2019 Aug; 154():42-49. PubMed ID: 31035244
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
[TBL] [Abstract][Full Text] [Related]
23. Effects of felbamate, gabapentin and lamotrigine on seizure parameters and excitability in the rat hippocampus.
Xiong ZQ; Stringer JL
Epilepsy Res; 1997 Jun; 27(3):187-94. PubMed ID: 9237053
[TBL] [Abstract][Full Text] [Related]
24. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.
Frye MA; Ketter TA; Kimbrell TA; Dunn RT; Speer AM; Osuch EA; Luckenbaugh DA; Cora-Ocatelli G; Leverich GS; Post RM
J Clin Psychopharmacol; 2000 Dec; 20(6):607-14. PubMed ID: 11106131
[TBL] [Abstract][Full Text] [Related]
25. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
26. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
Gilbert ME
Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
[TBL] [Abstract][Full Text] [Related]
27. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
[TBL] [Abstract][Full Text] [Related]
28. A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities.
Bhaumik S; Branford D; Duggirala C; Ismail IA
Seizure; 1997 Apr; 6(2):127-33. PubMed ID: 9153725
[TBL] [Abstract][Full Text] [Related]
29. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
[TBL] [Abstract][Full Text] [Related]
30. An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons.
Calabresi P; Centonze D; Marfia GA; Pisani A; Bernardi G
Br J Pharmacol; 1999 Feb; 126(3):689-96. PubMed ID: 10188980
[TBL] [Abstract][Full Text] [Related]
31. The NMDA receptor antagonist MK-801 has a dissociative effect on seizure activity of hippocampal-kindled cats.
Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
Pharmacol Biochem Behav; 1992 Dec; 43(4):1269-72. PubMed ID: 1475311
[TBL] [Abstract][Full Text] [Related]
32. Anticonvulsant action and long-term effects of gabapentin in the immature brain.
Cilio MR; Bolanos AR; Liu Z; Schmid R; Yang Y; Stafstrom CE; Mikati MA; Holmes GL
Neuropharmacology; 2001; 40(1):139-47. PubMed ID: 11077080
[TBL] [Abstract][Full Text] [Related]
33. The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling.
Gilbert ME
Epilepsy Res; 1994 Feb; 17(2):145-56. PubMed ID: 8194510
[TBL] [Abstract][Full Text] [Related]
34. The amygdala to periaqueductal gray pathway: plastic changes induced by audiogenic kindling and reversal by gabapentin.
Tupal S; Faingold CL
Brain Res; 2012 Sep; 1475():71-9. PubMed ID: 22841539
[TBL] [Abstract][Full Text] [Related]
35. Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.
Matagne A; Klitgaard H
Epilepsy Res; 1998 Jun; 31(1):59-71. PubMed ID: 9696301
[TBL] [Abstract][Full Text] [Related]
36. Antiepileptic effects of MK-801, a noncompetitive NMDA-receptor antagonist, in the low-frequency kindling model of epilepsy.
Minabe Y; Emori K; Shibata R; Kurachi M
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):755-61. PubMed ID: 1487858
[TBL] [Abstract][Full Text] [Related]
37. The effect of lamotrigine upon development of cortical kindled seizures in the rat.
O'Donnell RA; Miller AA
Neuropharmacology; 1991 Mar; 30(3):253-8. PubMed ID: 1852261
[TBL] [Abstract][Full Text] [Related]
38. Lamotrigine-resistant corneal-kindled mice: A model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery.
Koneval Z; Knox KM; White HS; Barker-Haliski M
Epilepsia; 2018 Jun; 59(6):1245-1256. PubMed ID: 29750337
[TBL] [Abstract][Full Text] [Related]
39. Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures.
Zierath D; Mizuno S; Barker-Haliski M
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902275
[TBL] [Abstract][Full Text] [Related]
40. Effect of lamotrigine on seizure development in a rat pentylenetetrazole kindling model.
Chen Y; He X; Sun Q; Fang Z; Zhou L
Brain Behav; 2017 Jul; 7(7):e00727. PubMed ID: 28729934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
